IASLC Newsletter - June 2018

Newer treatment options, biomarker-based patient segmentation and the availability of biomarker-based treatment approaches have added to treatment complexity over the years.

IASLC Newsletter - May 2018

With this corner, I would like to draw your attention to our new strategic plan.

IASLC Newsletter - April 2018

In my first president’s corner in November 2017, I discussed the IASLC's strategic plan, an initiative that will precisely define the organization's objectives and the time frame that will be necessary in order to achieve them.

IASLC Newsletter - March 2018

Immunotherapy has recently emerged as a new treatment modality in lung cancer, and reactivating immune responses that are silenced by immune checkpoints is an idea that has recently gained a lot of interest.

IASLC Newsletter - February 2018

In the last few years a series of quite complex projects, such as TracerX in United Kingdom, have flourished and generated data that has now been published.

IASLC Newsletter - January 2018

It's anticipated that precision medicine will improve all areas of medicine, including the ability to predict an individual’s risk of disease, the disease prognosis and the risk of side effects versus positive response to treatment approaches.